Showing results (31-40 of 81) with videos related to
Sort By:
Pageof 9
Asia-Pacific Journal of Clinical Oncology|January 31, 2022
Asbestos-related lung cancer: Clinical characteristics and survival outcomes in an Australian cohort seeking workers compensationRebecca A Hyland, Agata Chrzanowska, Kirsty Hannaford-Turner, et al.Journal of Pain and Symptom Management|August 3, 2019
Physical Activity for Symptom Management in Women With Metastatic Breast Cancer: A Randomized Feasibility Trial on Physical Activity and Breast MetastasesJasmine Yee, Glen M Davis, Daniel Hackett, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 15, 2011
Interpretation in consultations with immigrant patients with cancer: how accurate is it?Phyllis N Butow, David Goldstein, Melaine L Bell, et al.BMC Cancer|July 25, 2024
Pembrolizumab with platinum-based chemotherapy with or without epacadostat as first-line treatment for metastatic non-small cell lung cancer: a randomized, partially double-blind, placebo-controlled phase II studyMichael Boyer, Rina Hui, Damien Urban, et al.Patient Education and Counseling|April 2, 2013
Should culture affect practice? A comparison of prognostic discussions in consultations with immigrant versus native-born cancer patientsPhyllis N Butow, Ming Sze, Maurice Eisenbruch, et al.Clinical Lung Cancer|July 23, 2021
Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non-Small-Cell Lung Cancer (PACIFIC)Mark A Socinski, Mustafa Özgüroğlu, Augusto Villegas, et al.Lung Cancer (Amsterdam, Netherlands)|December 1, 2022
Usage of epidermal growth factor mutation testing and impact on treatment patterns in non-small cell lung cancer: An international observational studyJanakiraman Subramanian, Natasha B Leighl, Yoon-La Choi, et al.JTO Clinical and Research Reports|March 8, 2024
Symptomatic Pneumonitis With Durvalumab After Concurrent Chemoradiotherapy in Unresectable Stage III NSCLCJohan F Vansteenkiste, Jarushka Naidoo, Corinne Faivre-Finn, et al.Lung Cancer (Amsterdam, Netherlands)|December 7, 2020
Impact of prior chemoradiotherapy-related variables on outcomes with durvalumab in unresectable Stage III NSCLC (PACIFIC)Corinne Faivre-Finn, David R Spigel, Suresh Senan, et al.Breast (Edinburgh, Scotland)|November 8, 2020
Simplified phenotyping of CYP2D6 for tamoxifen treatment using the N-desmethyl-tamoxifen/ endoxifen ratioClara Inkyung Lee, Siew Kee Low, Ricardo Maldonado, et al.Pageof 9